Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis.

Tommi TervonenPareen VoraJaein SeoNicolas KrucienKevin MarshRaffaele De CaterinaUlrike WissingerMontse Soriano Gabarró

Published in: The patient (2021)

Patient preferences for the benefits and risks of low-dose aspirin differ significantly among people eligible for treatment as primary or secondary CVD prevention.

Keyphrases

low dose
cardiovascular disease
high dose
case report
decision making
cardiovascular events
antiplatelet therapy
metabolic syndrome
acute coronary syndrome
climate change
coronary artery disease
risk assessment
cardiovascular risk factors